AVM Biotechnology
Seattle, United States· Est. 2010
AVM Biotechnology - Home - Mobilizing the Supercharged Immune Armies Within - Immunotherapy for COVID-19, cancer, autoimmunity, and infectious diseases.
Private Company
Total funding raised: $15.5M
About
AVM Biotechnology - Home - Mobilizing the Supercharged Immune Armies Within - Immunotherapy for COVID-19, cancer, autoimmunity, and infectious diseases.
Small MoleculesCell & Gene Therapy
Funding History
11Total raised:$15.5M
Grant$1000KMay 10, 2023
Grant$964KMar 30, 2023
Grant$399KAug 5, 2022
Grant$1000KJun 10, 2022